0001062993-23-006334.txt : 20230308 0001062993-23-006334.hdr.sgml : 20230308 20230308200654 ACCESSION NUMBER: 0001062993-23-006334 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230306 FILED AS OF DATE: 20230308 DATE AS OF CHANGE: 20230308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HERSHBERG ROBERT CENTRAL INDEX KEY: 0001274139 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 23717824 MAIL ADDRESS: STREET 1: 3005 FIRST AVENUE CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp CENTRAL INDEX KEY: 0001478320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270907024 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1165 EASTLAKE AVE E CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-659-0067 MAIL ADDRESS: STREET 1: 1165 EASTLAKE AVE E CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: Adaptive TCR Corp DATE OF NAME CHANGE: 20091209 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2023-03-06 0001478320 Adaptive Biotechnologies Corp ADPT 0001274139 HERSHBERG ROBERT C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVENUE EAST SEATTLE WA 98109 1 0 0 0 Common Stock 2023-03-06 4 A 0 14775 0 A 75968 D Stock Option (right to buy) 8.46 2023-03-06 4 A 0 23329 0 A 2033-03-06 Common Stock 23329 23329 D The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates. /s/ Robert Hershberg by Stacy L Taylor, Attorney-in-Fact 2023-03-08